TCM — TCM A/S Income Statement
0.000.00%
- DKK622.14m
- DKK927.94m
- DKK1.11bn
- 79
- 72
- 77
- 92
Annual income statement for TCM A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,007 | 1,025 | 1,108 | 1,146 | 1,111 |
Cost of Revenue | |||||
Gross Profit | 280 | 273 | 255 | 234 | 218 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 860 | 890 | 970 | 1,049 | 1,066 |
Operating Profit | 147 | 135 | 138 | 96.9 | 45.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 142 | 131 | 136 | 89.4 | 27.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 111 | 102 | 111 | 70.5 | 21.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 111 | 102 | 111 | 70.5 | 21.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 111 | 102 | 111 | 70.5 | 21.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 11.7 | 10.6 | 12 | 8.34 | 3.27 |
Dividends per Share |